New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 29, 2012
14:49 EDTTHRXFDA panel: Theravance's Vibativ suitable when no alternatives in HAP
Reported by Bloomberg. Theravance shares remain halted for trade as FDA panel votes on Theravance drug for expanded indication to treat Hospital-acquired pneumonia, or HAP.
News For THRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for THRX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use